Rafael Holdings, Inc. (RFL.WS)

Market Cap	43.10M
Revenue (ttm)	706,000
Net Income (ttm)	-50.47M
Shares Out	24.91M
EPS (ttm)	-2.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	251
Open	0.0682
Previous Close	0.0682
Day's Range	0.0682 - 0.0682
52-Week Range	0.0990 - 0.9090
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 10, 2025

About RFL.WS

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), a stable analog of transient, acylated catalytic intermediates of lipoate currently un...

• Founded: 2017
• Employees: 31
• Stock Exchange: NYSE
• Ticker Symbol: RFL.WS
• Website: https://www.rafaelholdings.com

Financial Performance

In 2024, Rafael Holdings's revenue was $637,000, an increase of 128.32% compared to the previous year's $279,000. Losses were -$34.41 million, 1734.2% more than in 2023.